Literature DB >> 9270563

Multiple sclerosis lesion detection in the brain: a comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin echo.

M L Gawne-Cain1, J I O'Riordan, A J Thompson, I F Moseley, D H Miller.   

Abstract

We performed fast fluid-attenuated inversion recovery (fFLAIR) and conventional spin echo (CSE) brain MRI in 32 multiple sclerosis (MS) patients (eight each benign, relapsing-remitting, primary progressive, and secondary progressive). We compared number and site of lesions detected on each sequence. With initial separate assessment, we identified a total of 3,668 lesions-2,892 by CSE and 2,943 by fFLAIR. Following simultaneous review of the sequences, we identified an additional 217 lesions on fFLAIR and 229 on CSE. fFLAIR detected fewer lesions in the posterior fossa (66 versus 138, p = 0.001), fewer small (< 5 mm) discrete cerebral white matter lesions (671 versus 829, p = 0.0002), more subcortical lesions (542 versus 306, p < 0.0001), and more large discrete lesions (419 versus 385, p = 0.0006). Its relatively poor detection of posterior fossa lesions makes it premature for fFLAIR to replace CSE as the primary sequence for detecting MS lesions in clinical trials.

Entities:  

Mesh:

Year:  1997        PMID: 9270563     DOI: 10.1212/wnl.49.2.364

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy.

Authors:  M Inglese; M Rovaris; S Bianchi; L La Mantia; G L Mancardi; A Ghezzi; P Montagna; F Salvi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

2.  Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis.

Authors:  M Cercignani; M Bozzali; G Iannucci; G Comi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

Review 3.  Neuroimaging techniques in the diagnostic work-up of patients with the antiphospholipid syndrome.

Authors:  M Rovaris; C Pedroso; M Filippi
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

4.  In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis.

Authors:  F Bagnato; J A Butman; S Gupta; M Calabrese; L Pezawas; J M Ohayon; F Tovar-Moll; M Riva; M M Cao; S L Talagala; H F McFarland
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

Review 5.  Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1-Mechanisms, Efficacy, and Safety.

Authors:  C McNamara; G Sugrue; B Murray; P J MacMahon
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

6.  FLAIR imaging for multiple sclerosis: a comparative MR study at 1.5 and 3.0 Tesla.

Authors:  Rainald Bachmann; Ralf Reilmann; Wolfram Schwindt; Harald Kugel; Walter Heindel; Stefan Krämer
Journal:  Eur Radiol       Date:  2005-12-20       Impact factor: 5.315

7.  Improving Detection of Multiple Sclerosis Lesions in the Posterior Fossa Using an Optimized 3D-FLAIR Sequence at 3T.

Authors:  A Lecler; I El Sanharawi; J El Methni; O Gout; P Koskas; J Savatovsky
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-27       Impact factor: 3.825

Review 8.  MRI in the assessment and monitoring of multiple sclerosis: an update on best practice.

Authors:  Ulrike W Kaunzner; Susan A Gauthier
Journal:  Ther Adv Neurol Disord       Date:  2017-05-12       Impact factor: 6.570

Review 9.  Grey matter lesions in MS: from histology to clinical implications.

Authors:  Massimiliano Calabrese; Alice Favaretto; Valeria Martini; Paolo Gallo
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

Review 10.  High field MRI in the diagnosis of multiple sclerosis: high field-high yield?

Authors:  Mike P Wattjes; Frederik Barkhof
Journal:  Neuroradiology       Date:  2009-03-11       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.